MBIA (MBI) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
27 Feb, 2026Executive summary
Reported lower consolidated GAAP net loss for full year 2025 ($177M) compared to 2024 ($447M), driven by lower expenses and higher revenues, mainly due to favorable developments in PREPA exposure and portfolio runoff.
Fourth quarter 2025 GAAP net loss remained flat at $51M year-over-year, but adjusted net loss improved to $12M from $22M in Q4 2024, reflecting lower losses and loss adjustment expenses (LAE) at National.
National recorded a benefit from losses and LAE in 2025, primarily from the sale of PREPA bankruptcy claims at favorable prices and revised loss estimates.
Strategic options, including a potential sale of the company or its components, remain under consideration, with decisions guided by shareholder value.
Released full year and Q4 2025 financial results, available on company and SEC websites.
Financial highlights
Full year 2025 consolidated GAAP net loss: $177M ($-3.58/share) vs. $447M ($-9.43/share) in 2024.
Q4 2025 consolidated GAAP net loss: $51M ($-1.01/share), unchanged from Q4 2024.
Full year 2025 adjusted net income: $23M ($0.46/share) vs. adjusted net loss of $184M ($-3.90/share) in 2024.
Book value per share as of Dec 31, 2025: negative $44.27, down $3.28 from prior year.
National statutory net income for 2025: $88M vs. net loss of $133M in 2024.
Outlook and guidance
Ongoing focus on resolving remaining PREPA exposure, with limited progress due to unresolved legal and board issues.
Special dividend potential is under continuous review, with improved circumstances increasing likelihood, but subject to regulatory approval and portfolio runoff.
Strategic review continues, with all options open, including sale of the company or its parts, depending on shareholder value.
Latest events from MBIA
- Virtual annual meeting to vote on directors, pay, and auditors, with strong governance focus.MBI
Proxy filing23 Mar 2026 - Q3 2024 net loss narrowed to $56M, but PREPA risks and negative book value persist.MBI
Q3 202412 Feb 2026 - 2024 net loss narrowed, but adjusted losses rose and PREPA uncertainty persists.MBI
Q4 202412 Feb 2026 - Q2 net loss hit $254M on PREPA charges; book value fell to negative $39.07.MBI
Q2 20242 Feb 2026 - Annual meeting to vote on directors, pay, auditors, and incentive plan; board is majority independent.MBI
Proxy Filing2 Dec 2025 - Net loss narrowed, PREPA claim marketability improved, but litigation uncertainty persists.MBI
Q2 202523 Nov 2025 - Q1 2025 net loss narrows, PREPA risk remains, statutory capital and liquidity strong.MBI
Q1 202520 Nov 2025 - Q3 net loss narrowed on PREPA claim sales; strong capital and liquidity support future returns.MBI
Q3 202513 Nov 2025